甲型流感病毒核酸PCR检测试剂盒
- 供应商：广州欧边生物制品有限公司
- 供应商报价：面议
- 标签：甲型流感病毒核酸PCR检测试剂盒,-1,广州欧边生物制品有限公司
产品库
| 品牌 | 其他品牌 | 供货周期 | 现货 |
|---|
甲型流感病毒核酸PCR检测试剂盒
产品名称：甲型流感病毒核酸PCR检测试剂盒；
产品品Pai：创仑；
产品用途：本PCR-荧光探针法体外定性检测甲型流感病毒核酸；
产品规格：48T/盒；
保存条件：避光 -20度 保存。
我司还提供各种流感病毒、副流感病毒、呼吸道合胞病毒、冠状病毒、轮状病毒、杆菌、链球菌、热带病毒等等核酸检测试剂盒（PCR-荧光探针法），还有各种原料和质控品，随时欢迎您的来电： 杨
：
：
公司地址：广州清华科技园番禺区石楼镇创启路63号二期2幢101-103室
以下是我司出售的部分PCR产品
| 甲型流感病毒核酸检测试剂盒（PCR-荧光探针法） |
| 乙型流感病毒核酸检测试剂盒（PCR-荧光探针法） |
| 丙型流感病毒核酸检测试剂盒（PCR-荧光探针法） |
| 季节性流感病毒H1亚型核酸检测试剂盒（PCR-荧光探针法） |
| 季节性流感病毒H3亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型H1N1流感病毒（2009）RNA检测试剂盒（PCR-荧光探针法） |
| 人感染H7N9禽流感病毒核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H5亚型核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H7亚型核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H9亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H2亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H4亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H6亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H8亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H10亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H11亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H12亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H13亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H14亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H15亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒H16亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N1亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N2亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N3亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N4亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N5亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N6亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N7亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N8亚型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒N9亚型核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H5N1亚型核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H5N2亚型核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H10N8亚型核酸检测试剂盒（PCR-荧光探针法） |
| 乙型流感病毒Victoria谱系核酸检测试剂盒（PCR-荧光探针法） |
| 乙型流感病毒Yamagata谱系核酸检测试剂盒（PCR-荧光探针法） |
| 甲型/乙型/甲流H1N1（2009）三通道核酸检测试剂盒（PCR-荧光探针法） |
| 甲型/乙型流感病毒双通道核酸检测试剂盒（PCR-荧光探针法） |
| 甲型流感病毒/禽流感病毒H7亚型双通道核酸检测试剂盒（PCR-荧光探针法） |
| 季节性流感病毒H1/H3分型核酸检测试剂盒（PCR-荧光探针法） |
| 甲型H1N1流感病毒（2009）/季节性流感病毒H3亚型双通道核酸检测试剂盒（PCR-荧光探针法） |
| 乙型流感病毒Yamagata和Victoria谱系核酸检测试剂盒（PCR-荧光探针法） |
| 禽流感病毒H5/H7/H9分型三通道核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒通用型核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒Ⅰ型核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒Ⅱ型核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒Ⅲ型核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒Ⅳ型核酸检测试剂盒（PCR-荧光探针法） |
| 副流感病毒分型多通道核酸检测试剂盒（PCR-荧光探针法） |
| 呼吸道合胞病毒核酸检测试剂盒（PCR-荧光探针法） |
| 呼吸道合胞病毒A/B分型核酸检测试剂盒（PCR-荧光探针法） |
| 人偏肺病毒核酸检测试剂盒（PCR-荧光探针法） |
| 鼻病毒核酸检测试剂盒（PCR-荧光探针法） |
| 中东呼吸综合征冠状病毒（ORF1a基因）核酸检测试剂盒(PCR-荧光探针法) |
| 中东呼吸综合征冠状病毒（ORF1b基因）核酸检测试剂盒(PCR-荧光探针法) |
| 中东呼吸综合征冠状病毒（UpE基因）核酸检测试剂盒(PCR-荧光探针法) |
| 中东呼吸综合征冠状病毒（N2基因）核酸检测试剂盒(PCR-荧光探针法) |
| 中东呼吸综合征冠状病毒（ORF1a基因/ UpE基因）核酸检测试剂盒(PCR-双重荧光探针法) |
| 人冠状病毒HCoV-229E核酸检测试剂盒(PCR-荧光探针法) |
| 人冠状病毒HCoV-NL63核酸检测试剂盒(PCR-荧光探针法) |
| 人冠状病毒HCoV-OC43核酸检测试剂盒(PCR-荧光探针法) |
| 人冠状病毒HCoV-HKU1核酸检测试剂盒(PCR-荧光探针法) |
| 新型冠状病毒（SARS）核酸检测试剂盒(PCR-荧光探针法) |
| 人博卡病毒核酸检测试剂盒（PCR-荧光探针法） |
| 白喉杆菌核酸检测试剂盒（PCR-荧光探针法） |
| 百日咳杆菌核酸检测试剂盒（PCR-荧光探针法） |
| 嗜肺军团杆菌核酸检测试剂盒（PCR-荧光探针法） |
| 肺炎链球菌核酸检测试剂盒（PCR-荧光探针法） |
| 肺炎克雷伯菌核酸检测试剂盒（PCR-荧光探针法） |
| 流感嗜血杆菌核酸检测试剂盒（PCR-荧光探针法） |
“做核酸，到昆山。”１０年前，当昆山高新区喊出这句话的时候，谁也没有想到，１０年后的今天，这句话不仅成为小核酸领域发展的“风向标”，而且一个自主的小核酸及生物医药产业创新体系已在昆山高新区形成。
敢为人先的前瞻布局
做核酸，到昆山，用核酸，看昆山。在业界为昆山高新区的小核酸及生物医药产业发展叫好，并羡慕其好运的时候，回顾昆山高新区发展小核酸及生物医药产业的历程，人们会在羡慕之余，连声叹服昆山高新区人一直以来破斧沉舟、敢干敢试的创新创业精神。
小核酸是生物制药的一个新兴领域，它通过双链ＲＮＡ分子在ｍＲＮＡ水平关闭相应基因的表达或使该基因沉默，实现对疾病的诊断与ZL。这一技术被《科学》杂志和美国科学促进会评为２００２年十大科学成就之首。
在２００７年以前，昆山的生物医药产业近乎为零，仅有的几家生产辅药产品的传统制药厂也陆续关停。当时看来，昆山高新区似乎并不具备发展如此前沿、高端的小核酸产业的基础。然而，清华（启迪）科技园昆山分园和一位名叫梁子才的科学家的进驻，改变了这种状况。
２００７年，梁子才在昆山创办苏州瑞博生物技术有限公司，发展小核酸产业的火种由此被引到了昆山高新区。瑞博公司的股东不仅有梁子才，还包括张礼和院士、席真教授、金奇教授等，都是国内小核酸领域的*专家。
瑞博公司的成立给昆山高新区带来的不仅有高端人才，还有发展小核酸及生物医药产业的理念和信心。昆山市政府和昆山高新区下决心开始发展生物医药产业，并提出要把小核酸及生物医药产业作为继光电产业之后Z重要的产业扶持发展。在这个过程中，清华（启迪）科技园昆山分园成为Z重要的推手。昆山市委、市政府对发展小核酸产业形成高度共识，为小核酸及生物医药产业的发展创造了良好的政策环境。
２００８年９月，昆山小核酸产业基地奠基、小核酸研究所挂Pai。昆山，这个曾以加工制造业为主导产业的县级市，开始尝试在生物医药领域走出一条自主研发的道路。对此，ZG科学院院士陈润生曾赞叹：“一个县级市敢于在小核酸技术领域布局谋篇，体现了昆山科技创新的远见卓识。”
１０年不改初心出成绩
十年磨一剑。经过近１０年的努力，从小核酸起步，昆山高新区建设了覆盖小核酸、化学药、大分子蛋白药、生物材料等在内的高科技生物医药产业园。目前，全国８０％的小核酸服务及科研试剂供应在这里聚集，９０％的小核酸原料及药物在这里汇聚。瑞博、泽璟、博创同康等５０多家新药研发、YL器械、药物研发服务外包企业在这里扎根发展；建设了张礼和、陈新滋等１０多位科学家冠名的研究室，汇聚了ZY“千人计划”人才１１人，承担了国家“重大新药创制”等重大科技专项１４项。现有１０个创新品种，包括４个１．１类新药正在临床研究，５０多个创新药物和YL器械处于临床前研究阶段。
"Do nucleic acid, to Kunshan." 10 years ago, when the Kunshan high tech Zone to shout out this word, no one would have thought that 10 years later, this sentence is not only development in the field of global small nucleic acid "vane", and an independent small nucleic acid and biological pharmaceutical industry innovation system has been formed in the Kunshan high tech zone.
A prospective layout of the first person
Do nucleic acid, go to Kunshan, use nucleic acid, look at Kunshan. Good for small nucleic acid and biological medicine industry development in Kunshan high tech Zone in the industry, and admire the good luck, reviewing the history of the development of small nucleic acid and biological medicine industry in Kunshan high tech Zone, people will be in envy, admiration repeatedly in Kunshan high tech Zone has been broken, a hatchet dare do dare to try innovative spirit.
Small nucleic acid is a new field of biopharmaceuticals. It can shut down the expression of corresponding genes at mRNA level or silence the gene by double stranded RNA molecules, so as to realize the diagnosis and treatment of diseases. This technology is the first of the ten scientific achievements in 2002 by the journal Science and the American Association for the promotion of science.
Before 2007, the bio pharmaceutical industry in Kunshan was almost zero, and only a few traditional pharmaceutical factories producing auxiliary drugs have been shut down. At that time, it seemed that Kunshan hi-tech zones did not seem to have the basis for developing such advanced and high-end small nucleic acid industries. However, the Kunshan branch of the Tsinghua Science and Technology Park and a scientist named Liang Zicai changed the situation.
In 2007, Liang Zicai was founded in Kunshan, Suzhou Ruibo Biological Technology Co. Ltd., the development of small nucleic acid industry is led to the fire from the Kunshan high tech zone. Our company's shareholders not only Liang Zicai, including Zhang Li and academician, Professor, I really like Professor Jin Qi, are leading experts in the field of domestic small nucleic acid.
The establishment of Ruibo company brought to Kunshan high tech Zone is not only high-end talent, as well as the development of small nucleic acid and bio pharmaceutical industry and the concept of confidence. Kunshan municipal government and the Kunshan high tech Zone is determined to start the development of bio pharmaceutical industry, and put forward to support the development of small nucleic acid and biological pharmaceutical industry as the most important after the optical power industry industry. In this process, the Kunshan branch of Tsinghua (enlightening) science and technology park has become the most important push. The municipal Party committee and municipal government of Kunshan have formed a high consensus on the development of small nucleic acid industry, creating a good policy environment for the development of small nucleic acid and the development of bio pharmaceutical industry.
In September 2008, the foundation of the Kunshan small nucleic acid industry base and the Research Institute of small nucleic acid were listed. In Kunshan, the county city, which used to be the leading manufacturing industry, began to try to get out of a path of independent research and development in the field of biological medicine. In this regard, Chen Runsheng China academician had praise: "a county-level city to layout in the technical field of small nucleic acid Moupian, embodies the innovation of Kunshan science and technology foresight."
10 years do not change the initial achievement
Ten years of grinding sword. After nearly 10 years of efforts, starting from small nucleic acids, Kunshan hi tech Zone has built high-tech biological medicine industrial parks covering small nucleic acids, chemical drugs, macromolecular protein drugs and biological materials. At present, 80% of the country's small nucleic acid services and scientific research reagents are gathered here, and 90% of the small nucleic acid materials and drugs are gathered here. Ruibo, Ze Jing, Bo Tong Kang and other more than 50 new drug research and development, medical equipment, pharmaceutical research and development service outsourcing enterprises rooted in the development of laboratory construction here; Zhang Lihe, Chen Xinzi and other more than 10 scientists named, brought together the central people plan talent 11, assumed the major national major new drug other special science and technology 14. There are 10 innovative varieties, including 4, 1.1, new drugs, which are being clinical research, and more than 50 innovative drugs and medical devices are in pre clinical research stage.
